申请人:Von Itzstein Mark Laurence
公开号:US20050124559A1
公开(公告)日:2005-06-09
A compound of general formula (I):
wherein R
1
and R
2
may be the same or different and are selected from the group consisting of hydrogen, optionally substituted C
4-30
alkyl and optionally substituted C
4-30
alkenyl, provided that R
1
and R
2
may not both be hydrogen, or R
1
and R
2
together with the nitrogen atom from which they depend form a saturated or unsaturated, optionally substituted heterocyclic group which may include additional heteroatoms selected from the group consisting of O, N and S, or R
1
and R
2
together with the nitrogen atom from which they depend form an optionally substituted lactam moiety;
X
1
is selected from the group consisting of OR
3
, SR
3
, NR
3
R′
3
, hydrogen, halogen, CN, C(O)NR
3
R′
3
, C(O)OR
3
, OSO
3
R
3
, OPO
3
R
3
, NNR
3
R′
3
, SNR
3
R′
3
, NHSR
3
, SSR
3
and substituted alkyl;
X
2
is selected from the group consisting of OR
4
, SR
4
, NR
4
R′
4
, hydrogen, halogen, CN, C(O)NR
4
R′
4
, C(O)OR
4
, OSO
3
R
4
, OPO
3
R
4
, NNR
4
R′
4
, SNR
4
R′
4
, NHSR
4
, SSR
4
and substituted alkyl;
X
3
is selected from the group consisting of OR
5
, SR
5
, NR
5
R′
5
, hydrogen, halogen, CN, C(O)NR
5
R′
5
, C(O)OR
5
, OSO
3
R
5
, OPO
3
R
5
R′
5
, NNR
5
R′
5
, SNR
5
R′
5
, NHSR
5
, SSR
5
and substituted alkyl;
X
4
is selected from the group consisting of OR
6
, SR
6
, NR
6
R′
6
, hydrogen, halogen, CN, C(O)NR
6
R′
6
, C(O)OR
6
, OSO
3
R
6
, OPO
3
R
6
R′
6
, NNR
6
R′
6
, SNR
6
R′
6
, NHSR
6
, SSR
6
and substituted alkyl;
R
3
, R′
3
, R
4
, R′
4
, R
5
, R′
5
, R
6
and R′
6
are the same or different and are selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted aralkyl, optionally substituted aryl, optionally substituted acyl and a carbohydrate moiety; or a pharmaceutically acceptable salt thereof.
通式(I)的化合物:其中R1和R2可以相同或不同,并且从氢,可选取代的C4-30烷基和可选取代的C4-30烯基的群中选择,前提是R1和R2不能同时为氢,或者R1和R2与它们所依赖的氮原子一起形成饱和或不饱和的、可选取代的杂环基团,该基团可以包括从O、N和S的群中选择的额外杂原子,或者R1和R2与它们所依赖的氮原子一起形成可选取代的内酰胺基团;X1从OR3、SR3、NR3R′3、氢、卤素、CN、C(O)NR3R′3、C(O)OR3、OSO3R3、OPO3R3、NNR3R′3、SNR3R′3、NHSR3、SSR3和取代烷基的群中选择;X2从OR4、SR4、NR4R′4、氢、卤素、CN、C(O)NR4R′4、C(O)OR4、OSO3R4、OPO3R4、NNR4R′4、SNR4R′4、NHSR4、SSR4和取代烷基的群中选择;X3从OR5、SR5、NR5R′5、氢、卤素、CN、C(O)NR5R′5、C(O)OR5、OSO3R5、OPO3R5R′5、NNR5R′5、SNR5R′5、NHSR5、SSR5和取代烷基的群中选择;X4从OR6、SR6、NR6R′6、氢、卤素、CN、C(O)NR6R′6、C(O)OR6、OSO3R6、OPO3R6R′6、NNR6R′6、SNR6R′6、NHSR6、SSR6和取代烷基的群中选择;R3、R′3、R4、R′4、R5、R′5、R6和R′6可以相同或不同,并且从氢、可选取代的烷基、可选取代的芳基烷基、可选取代的芳基、可选取代的酰基和碳水化合物基团中选择;或其药学上可接受的盐。